Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Cash Flow Reinvestment Rate
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Cash Flow Reinvestment Rate of 1.44x as of September 2025, reinvesting CN¥30.36 Million (capex CN¥30.36 Million ) from operating cash flow of CN¥21.03 Million. See Shanghai Yizhong Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2022–2024)
Historical reinvestment intensity for Shanghai Yizhong Pharmaceutical Co Ltd across 3 annual periods. For the full cash flow conversion analysis, see Shanghai Yizhong Pharmaceutical Co Ltd cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Year-by-year capital reinvestment analysis for Shanghai Yizhong Pharmaceutical Co Ltd. See 688091 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.60x | CN¥102.42 Million | CN¥39.44 Million | CN¥80.04 Million | ▲ +367.8% |
| 2023 | 0.56x | CN¥48.06 Million | CN¥86.55 Million | CN¥8.78 Million | ▼ -88.6% |
| 2022 | 4.86x | CN¥538.15 Million | CN¥110.78 Million | CN¥35.88 Million | — |